Invest in Meiji
The combined strengths of our food and pharmaceutical businesses, plus an emphasis on sustainability, help Meiji deliver long-term growth and stakeholder returns.
Products with the highest market shares in Japan
-
- Yogurt
- No.1
- 35.8%
- Market scale 473.0 billion yen
- *1
-
- Chocolate
- No.1
- 24.7%
- Market scale 427.4 billion yen
- *1
-
- Cheese
- No.3
- 10.0%
- Market scale 211.1 billion yen
- *1
-
- Protein
- No.1
- 36.8%
- Market scale 133.7 billion yen
- *2
-
- Systemic antibacterial drugs
- No.1
- 23.2%
- Market scale 190.4 billion yen
- *3
-
- Influenza HA Vaccine
- No.1
- 29.3%
- Market scale 72.8 billion yen
- *3
Food and pharmaceuticals: strength in synergy
Meiji contributes to health and wellness across a number of market categories including food, nutritional products, and pharmaceuticals. Not only does this give us a broad portfolio, we're able to leverage these different strengths into integrated R&D that creates new health value for consumers and society.
Main areas of business
- Yogurt & cheese
- Nutrition
- Chocolate & gummy
- Drinking milk
- Business-to-Business
- Frozen dessert & ready meal
- Overseas
- Other / domestic subsidiaries
- Domestic ethical pharmaceuticals
- Overseas ethical pharmaceuticals
- Human vaccines
- Veterinary drugs
Net sales ratio by segment (FYE 3/2024)
- Food Business
- 81.4%
- 900.1 billion yen
- Pharmaceutical Business
- 18.6%
- 206.1 billion yen
Net sales ratio by region (FYE 3/2024)
- Japan
- 88.0%
- 973.1 billion yen
- Overseas
- 12.0%
- 132.3 billion yen
Sustainability: a healthier society
Meiji is committed to fulfilling its environmental and social responsibilities. As professionals in food and health, we're uniquely able to contribute to the health and wellness of individuals, which in turn leads to a healthier society and planet. Our environmental and social policies and performance are regularly updated on our main Sustainability page.
Improved performance and dividends
The Meiji Group has achieved long-term stable growth and shareholder returns through the sales expansion of core businesses.
Data Book FY2023-From April 1, 2023 to March 31, 2024-
Data Book FY2023-From April 1, 2023 to March 31, 2024- (Excel 5,302KB)